VSee Health, Inc. Regains Compliance with Nasdaq Stockholders' Equity Requirement

About this update from Vsee Health, Inc.

[{"type":"text","content":"SAN JOSE, CALIFORNIA / ACCESS Newswire / December 12, 2025 / VSee Health, Inc. (Nasdaq:VSEE, VSEEW), a leading provider of telehealth and digital health solutions, today announced that it has regained compliance with Nasdaq Listing Rule 5550(b)(1) (the "Minimum Equity Rule").","length":286,"tagName":"p"},{"type":"text","content":"As previously disclosed, on September 2, 2025, the Company received notice from Nasdaq that its stockholders' equity had fallen below the $2.5 million minimum required for continued listing on The Nasdaq Capital Market. Following a hearing on September 9, 2025, the Nasdaq Hearings Panel granted the Company an exception through December 1, 2025, to demonstrate compliance.","length":377,"tagName":"p"},{"type":"text","content":"The Company is pleased to report that, through a series of strategic capital transactions completed after September 30, 2025, it has successfully increased its stockholders' equity to approximately $9.5 million on a pro forma basis as of December 1, 2025. These transactions included:","length":288,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Full conversion of multiple outstanding convertible notes into common stock;","length":76,"tagName":"p"}]},{"val":[{"type":"text","content":"Cash exercise and exchange of certain public warrants; and","length":58,"tagName":"p"}]},{"val":[{"type":"text","content":"A $6.0 million private placement of common stock (or pre-funded warrants) with accompanying warrants completed on November 25, 2025.","length":132,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":266,"olType":false},{"type":"text","content":"A pro forma balance sheet reflecting these transactions as of December 1, 2025, was filed with the Securities and Exchange Commission on Form 8-K/A on December 11, 2025.","length":169,"tagName":"p"},{"type":"text","content":""We are very pleased to have regained compliance with Nasdaq's continued " minimum equity listing requirement," said Dr. Imo Aisiku, Co-Chief Executive Officer and of VSee Health. "These transactions have significantly strengthened our balance sheet, eliminated substantial debt and derivative liabilities, and provided the Company with additional working capital to execute our growth strategy in telehealth, remote patient monitoring, and digital he...

More updates from Vsee Health, Inc.